Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Histology-Independent Study of the Cyclin Inhibitor Palbociclib in Patients With Advanced Cancer Harboring Aberrations in the Cyclin Pathway

NCT03123744 is registered in ClinicalTrials.gov with Razelle Kurzrock, MD as lead sponsor.

NCT NCT03123744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Histology-Independent Study of the Cyclin Inhibitor Palbociclib in Patients With Advanced Cancer Harboring Aberrations in the Cyclin Pathway
Lead sponsor
Razelle Kurzrock, MD
Phase
Phase 2
Overall status
Withdrawn
Start date
July 1, 2018
Completion date
February 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, advanced